Early Bronchodilatory Effects of Budesonide/Formoterol pMDI Compared with Fluticasone/Salmeterol DPI and Albuterol pMDI: 2 Randomized Controlled Trials in Adults with Persistent Asthma Previously Treated with Inhaled Corticosteroids

Author： Hampel Frank   Martin Paula   Mezzanotte William  

Publisher： Informa Healthcare

ISSN： 0277-0903

Source： Journal of Asthma, Vol.45, Iss.4, 2008-05, pp. : 265-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluticasone/Formoterol Combination Therapy versus Budesonide/Formoterol for the Treatment of Asthma: A Randomized, Controlled, Non-Inferiority Trial of Efficacy and Safety

By Bodzenta-Lukaszyk Anna   Buhl Roland   Balint Beatrix   Lomax Mark   Spooner Kay   Dissanayake Sanjeeva  

Journal of Asthma, Vol. 49, Iss. 10, 2012-12 ,pp. : 1060-1070

Informa Healthcare

Access to resources Recommend Favorite

Combination Therapy with Single Inhaler Budesonide/Formoterol Compared with High Dose of Fluticasone Propionate Alone in Patients with Moderate Persistent Asthma

By Bateman E.D.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 3, 2003-01 ,pp. : 275-281

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Fluticasone Propionate/Salmeterol HFA 134A MDI in Patients with Mild‐to‐Moderate Persistent Asthma

By Pearlman David   Peden David   Condemi John   Weinstein Steven   White Martha   Baitinger Leslie   Scott Catherine   Ho Shu   House Karen   Dorinsky Paul  

Journal of Asthma, Vol. 41, Iss. 8, 2004-01 ,pp. : 797-806

Informa Healthcare

Access to resources Recommend Favorite

Formoterol Delivered via the Dry Powder Aerolizer® Inhaler Versus Albuterol MDI and Placebo in Mild-to-Moderate Asthma: A Randomized, Double-Blind, Double-Dummy Trial

By Pleskow W.   LaForce C. F.   Yegen Ü.   Matos D.   Della Cioppa G.  

Journal of Asthma, Vol. 40, Iss. 5, 2003-09 ,pp. : 505-514

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler

By Berger William E.   Noonan Michael J.  

Journal of Asthma, Vol. 47, Iss. 4, 2010-05 ,pp. : 447-459

Informa Healthcare

Access to resources Recommend Favorite